Arrow Investment Advisors LLC Sells 15,858 Shares of Global Medical REIT Inc. $GMRE

Arrow Investment Advisors LLC lessened its holdings in shares of Global Medical REIT Inc. (NYSE:GMRE) by 71.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,374 shares of the company’s stock after selling 15,858 shares during the period. Arrow Investment Advisors LLC’s holdings in Global Medical REIT were worth $215,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Geode Capital Management LLC lifted its position in Global Medical REIT by 3.0% during the 2nd quarter. Geode Capital Management LLC now owns 1,748,799 shares of the company’s stock valued at $12,121,000 after acquiring an additional 50,959 shares during the period. Invesco Ltd. grew its holdings in Global Medical REIT by 30.5% in the second quarter. Invesco Ltd. now owns 1,518,668 shares of the company’s stock worth $10,524,000 after purchasing an additional 355,355 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Global Medical REIT by 8.6% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 1,514,954 shares of the company’s stock valued at $10,499,000 after purchasing an additional 119,538 shares in the last quarter. Man Group plc lifted its holdings in shares of Global Medical REIT by 1.7% during the second quarter. Man Group plc now owns 600,943 shares of the company’s stock valued at $4,165,000 after purchasing an additional 10,192 shares during the last quarter. Finally, Cutler Capital Management LLC boosted its position in shares of Global Medical REIT by 3.5% in the 2nd quarter. Cutler Capital Management LLC now owns 472,938 shares of the company’s stock worth $3,277,000 after purchasing an additional 15,900 shares in the last quarter. 57.52% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

GMRE has been the subject of a number of analyst reports. Citizens Jmp raised Global Medical REIT from a “market perform” rating to an “outperform” rating and set a $40.00 price objective for the company in a research report on Monday, October 13th. Citigroup raised Global Medical REIT to an “outperform” rating in a research note on Monday, October 13th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Global Medical REIT in a research report on Monday, December 29th. Wall Street Zen cut shares of Global Medical REIT from a “hold” rating to a “sell” rating in a research note on Saturday, November 8th. Finally, Robert W. Baird cut their target price on Global Medical REIT from $45.00 to $41.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 11th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $41.50.

Global Medical REIT Price Performance

NYSE GMRE opened at $35.96 on Wednesday. Global Medical REIT Inc. has a 52 week low of $29.05 and a 52 week high of $45.75. The firm has a market capitalization of $482.22 million, a P/E ratio of -143.84 and a beta of 1.18. The company has a quick ratio of 0.52, a current ratio of 0.52 and a debt-to-equity ratio of 1.65. The company has a 50-day moving average price of $33.88 and a 200-day moving average price of $34.18.

Global Medical REIT (NYSE:GMRE) last announced its earnings results on Tuesday, November 4th. The company reported $1.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.07. Global Medical REIT had a net margin of 0.79% and a return on equity of 0.25%. The company had revenue of $37.23 million during the quarter, compared to analyst estimates of $38.15 million. Global Medical REIT has set its FY 2025 guidance at 4.500-4.600 EPS. Equities research analysts anticipate that Global Medical REIT Inc. will post 0.81 earnings per share for the current year.

Global Medical REIT Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, January 9th. Investors of record on Friday, December 19th were issued a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a yield of 8.3%. The ex-dividend date of this dividend was Friday, December 19th. Global Medical REIT’s dividend payout ratio (DPR) is currently -1,200.00%.

Insiders Place Their Bets

In related news, CEO Mark Okey Decker, Jr. purchased 10,000 shares of the business’s stock in a transaction on Friday, November 14th. The stock was acquired at an average price of $32.58 per share, with a total value of $325,800.00. Following the completion of the acquisition, the chief executive officer owned 44,774 shares of the company’s stock, valued at approximately $1,458,736.92. This trade represents a 28.76% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 8.50% of the company’s stock.

Global Medical REIT Company Profile

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.